Cargando…
Corrigendum: Utility of S100A12 as an Early Biomarker in Patients With ST-Segment Elevation Myocardial Infarction
Autores principales: | Zhang, Xiaolin, Cheng, Minghui, Gao, Naijing, Li, Yi, Yan, Chenghui, Tian, Xiaoxiang, Liu, Dan, Qiu, Miaohan, Wang, Xiaozeng, Luan, Bo, Deng, Jie, Wang, Shouli, Tian, Hongyan, Wang, Geng, Ma, Xinliang, Stone, Gregg W., Han, Yaling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906508/ https://www.ncbi.nlm.nih.gov/pubmed/35282371 http://dx.doi.org/10.3389/fcvm.2022.840102 |
Ejemplares similares
-
Utility of S100A12 as an Early Biomarker in Patients With ST-Segment Elevation Myocardial Infarction
por: Zhang, Xiaolin, et al.
Publicado: (2021) -
Role of Neutrophil-Derived S100B in Acute Myocardial Infarction Patients From the Han Chinese Population
por: Cheng, Minghui, et al.
Publicado: (2021) -
Corrigendum: Untargeted metabolomics identified kynurenine as a predictive prognostic biomarker in acute myocardial infarction
por: Zhang, Xiaolin, et al.
Publicado: (2023) -
A Novel Multiple Risk Score Model for Prediction of Long-Term Ischemic Risk in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: Insights From the I-LOVE-IT 2 Trial
por: Qiu, Miaohan, et al.
Publicado: (2022) -
Effect of dual antiplatelet therapy prolongation in acute coronary syndrome patients with both high ischemic and bleeding risk: insight from the OPT-CAD study
por: Na, Kun, et al.
Publicado: (2023)